Watch the video below:
Oops! We could not locate your form.
Related Content:
Study Finds Trump’s Most Favored Nation Drug Proposal Could Still Raise Out-of-Pocket Costs Without PBM Reform
BOSTON — Out-of-pocket drug costs for seniors may rise under President Trump’s Most Favored Nation (MFN) proposal if policymakers do not address the role of…
Read more
Pioneer Institute Launches Tracker Showing Drug Price Controls Are Raising Out-of-Pocket Costs for Medicare Patients
A new data tool from Pioneer Institute reveals that federal drug price controls—intended to reduce out-of-pocket costs for seniors—are instead making many prescription drugs…
Read more
Pioneer Institute Study Calls for Reforms to Ensure that Pharmacy Benefit Manager Practices Benefit Patients, Healthcare Payers
Congress likely to take up PBM reform early this year; Pioneer Institute Calls for PBM’s to be more transparent
Read more
Opinion: Legislature should act on bill to limit out-of-pocket drug costs
S. 609, a bill that would limit out-of-pocket costs for patients paying for prescription drugs, is a clear step in the right direction. Massachusetts…
Read more
Opinion: Drug patents aren’t a ‘necessary evil.’ They save lives.
Drug patents are one of the most important public policy innovations in all of human history, and a boon to patients awaiting cures. Inventions…
Read more
Study: High List Prices and Deep Discounts for Prescription Drugs Hurt Poor and Sick Patients
A new Pioneer Institute study illustrates how the current system of drug pricing and discounts leads to patients with challenging diseases being charged huge…
Read more
A Federal Drug Discount Program for the Wealthy
The combination of legal disputes, a growing data repository and investigative reports have necessarily put the 340B Drug Pricing Program under the microscope. Combined…
Read more
First-of-Its-Kind Interactive Mapping Tool Reveals Extent of For-Profit Entities Benefitting from the 340B Drug Pricing Program
Today, Pioneer Institute released a first-of-its-kind, 50-state mapping tool and database highlighting the troubling way in which hospitals and covered entities leverage unlimited pharmacy…
Read more
